Compare CSTM & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTM | ICUI |
|---|---|---|
| Founded | 2010 | 1984 |
| Country | France | United States |
| Employees | 11500 | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | 2012 | 1995 |
| Metric | CSTM | ICUI |
|---|---|---|
| Price | $27.58 | $160.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $30.75 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 1.3M | 210.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 405.26 | 100.62 |
| EPS | 1.42 | ★ 1.96 |
| Revenue | ★ $8,449,000,000.00 | $2,231,262,000.00 |
| Revenue This Year | $21.46 | N/A |
| Revenue Next Year | $0.50 | $4.46 |
| P/E Ratio | ★ $19.11 | $85.50 |
| Revenue Growth | ★ 15.19 | N/A |
| 52 Week Low | $13.60 | $112.50 |
| 52 Week High | $36.99 | $192.85 |
| Indicator | CSTM | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 33.73 |
| Support Level | $27.02 | $138.91 |
| Resistance Level | $30.75 | $191.07 |
| Average True Range (ATR) | 0.98 | 4.39 |
| MACD | 0.08 | -2.90 |
| Stochastic Oscillator | 58.70 | 3.98 |
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.